JENNIFER HALLIBURTON: Open Payments
NPI 1962825562 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $461 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Dexcom, Inc. | 3 | $54 |
| ABBVIE INC. | 1 | $28 |
| Eisai Inc. | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: FARXIGA, Dexcom G6 Transmitter, UBRELVY, Leqembi, TZIELD, GARDASIL 9, PAXLOVID, The Cologuard Plus Collection Kit.
Industry payments across AR — which companies pay providers there.
